Study to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung Cancer

NCT06555263 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Terminated Early

Conditions

Lung Cancer
Lung Cancer Metastatic
Lung Cancer, Nonsmall Cell
Lung Cancer Non-Small Cell Stage IIIB
Lung Cancer Non-small Cell Stage IV
Lung Cancer, Non-small Cell

Interventions

DRUG: Luveltamab tazevibulin

Sponsor

Sutro Biopharma, Inc.